Compare · HSCS vs ZBH
HSCS vs ZBH
Side-by-side comparison of HeartSciences Inc. (HSCS) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HSCS and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH is the larger of the two at $17.44B, about 2139.0x HSCS ($8.2M).
- Over the past year, HSCS is down 34.4% and ZBH is down 4.4% - ZBH leads by 29.9 points.
- HSCS has been more active in the news (16 items in the past 4 weeks vs 11 for ZBH).
- ZBH has more recent analyst coverage (25 ratings vs 0 for HSCS).
- Company
- HeartSciences Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $2.50+0.00%
- $90.06-1.10%
- Market cap
- $8.2M
- $17.44B
- 1M return
- +43.27%
- +1.69%
- 1Y return
- -34.38%
- -4.44%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 16
- 11
- Recent ratings
- 0
- 25
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest HSCS
- SEC Form DEFA14A filed by HeartSciences Inc.
- HeartSciences Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by Officer Watson Danielle
- SEC Form DEFA14A filed by HeartSciences Inc.
- HeartSciences Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Leadership Update, Financial Statements and Exhibits
- SEC Form DEFA14A filed by HeartSciences Inc.
- SEC Form DEFA14A filed by HeartSciences Inc.
- SEC Form DEFA14A filed by HeartSciences Inc.
- Officer Simpson Andrew was granted 425,000 shares, increasing direct ownership by 571% to 499,382 units (SEC Form 4)
- SEC Form DEFA14A filed by HeartSciences Inc.
Latest ZBH
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
- Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results
- BMO Capital Markets initiated coverage on Zimmer Biomet with a new price target
- SEC Form 4 filed by Director Hilado Maria Teresa
- SEC Form 4 filed by Director Kurdikar Devdatt
- SEC Form 4 filed by Director Hagemann Robert
- SEC Form 4 filed by Director Higgins Arthur J
- SEC Form 4 filed by Director Kolli Sreelakshmi
- SEC Form 4 filed by Director Farrell Michael J.
- SEC Form 4 filed by Director Shapiro Louis